SCHEMBL1817178

SCHEMBL1817178

S=C(NCCc1ccc2c(n1)NCCC2)NCc1ccc(Cl)c(Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 6/20 0.55
ITGAV P06756 10/20 0.47
ITGB3 P05106 8/20 0.47
ITGB6 P18564 4/20 0.47
ITGB8 P26012 3/20 0.47
ITGB5 P18084 2/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
MAPK1 P28482 1/20 0.46
ITGB1 P05556 4/20 0.43
ITGA5 P08648 3/20 0.43
RORC P51449 1/20 0.40
ITGA4 P13612 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3131367 0.88 CXCR4 (0.58) CXCR4ITGAVITGB3ITGB6ITGB8
SCHEMBL3133173 0.84 ITGAV (0.51) CXCR4ITGAVITGB3ITGB6ITGB8
SCHEMBL1819351 0.83 CXCR4 (0.45) CXCR4ITGAVITGB3ITGB6ITGB8
SCHEMBL1819353 0.83 CXCR4 (0.45) CXCR4ITGAVITGB3ITGB6ITGB8
SCHEMBL13355445 0.83 ITGAV (0.55) CXCR4ITGAVITGB3ITGB6ITGB8
SCHEMBL13355164 0.83 ITGB3 (0.56) CXCR4ITGAVITGB3ITGB6ITGB8
SCHEMBL13355442 0.82 ITGB3 (0.59) CXCR4ITGAVITGB3ITGB6ITGB8
SCHEMBL3139006 0.81 CXCR4 (0.51) CXCR4ITGAVITGB3ITGB6ITGB8
SCHEMBL3135105 0.80 ITGAV (0.47) CXCR4ITGAVITGB3ITGB6ITGB8
SCHEMBL3269318 0.80 ITGAV (0.46) CXCR4ITGAVITGB3ITGB6ITGB8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011060394-A1 COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2011-05-19 WO disclosed
WO-2011060395-A1 CYCLIC UREAS USEFUL AS HIV INHIBITORS SCHERING CORPORATION (US) 2011-05-19 WO disclosed
WO-2010057101-A2 COMPOUNDS USEFUL AS HIV BLOCKERS SCHERING CORPORATION (US) 2010-05-20 WO disclosed